Bart Goldhoorn

1.0k total citations
8 papers, 768 citations indexed

About

Bart Goldhoorn is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, Bart Goldhoorn has authored 8 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pediatrics, Perinatology and Child Health and 3 papers in Physiology. Recurrent topics in Bart Goldhoorn's work include Neonatal Health and Biochemistry (5 papers), Erythrocyte Function and Pathophysiology (3 papers) and Biochemical and Molecular Research (2 papers). Bart Goldhoorn is often cited by papers focused on Neonatal Health and Biochemistry (5 papers), Erythrocyte Function and Pathophysiology (3 papers) and Biochemical and Molecular Research (2 papers). Bart Goldhoorn collaborates with scholars based in Netherlands and United States. Bart Goldhoorn's co-authors include Ronald P.J. Oude Elferink, Piter J. Bosma, Jayanta Roy Chowdhury, Jurgen Seppen, Conny Bakker, N R Chowdhury, Plm Jansen, Peter L. M. Jansen, P. L. M. Jansen and Namita Roy Chowdhury and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Bart Goldhoorn

8 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart Goldhoorn Netherlands 7 528 464 165 142 107 8 768
Gemma Monaghan United Kingdom 11 640 1.2× 563 1.2× 269 1.6× 257 1.8× 245 2.3× 11 1.1k
Maureen Boxer United Kingdom 12 226 0.4× 242 0.5× 154 0.9× 113 0.8× 101 0.9× 14 625
Baljit S. Sappal United States 8 248 0.5× 368 0.8× 101 0.6× 106 0.7× 96 0.9× 8 757
Anna Demina United States 9 464 0.9× 554 1.2× 176 1.1× 104 0.7× 208 1.9× 16 987
Ching‐Shan Huang Taiwan 13 603 1.1× 314 0.7× 342 2.1× 40 0.3× 76 0.7× 27 771
Bertram F. Felsher United States 15 406 0.8× 620 1.3× 171 1.0× 37 0.3× 23 0.2× 21 849
P. G. Cole United Kingdom 7 338 0.6× 237 0.5× 109 0.7× 19 0.1× 44 0.4× 10 516
K Miyai Japan 13 89 0.2× 159 0.3× 55 0.3× 66 0.5× 208 1.9× 36 518
Tomoaki Higuchi Japan 13 105 0.2× 155 0.3× 52 0.3× 99 0.7× 221 2.1× 44 526
Russell R. Moores United States 14 180 0.3× 105 0.2× 83 0.5× 8 0.1× 46 0.4× 38 538

Countries citing papers authored by Bart Goldhoorn

Since Specialization
Citations

This map shows the geographic impact of Bart Goldhoorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Goldhoorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Goldhoorn more than expected).

Fields of papers citing papers by Bart Goldhoorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Goldhoorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Goldhoorn. The network helps show where Bart Goldhoorn may publish in the future.

Co-authorship network of co-authors of Bart Goldhoorn

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Goldhoorn. A scholar is included among the top collaborators of Bart Goldhoorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Goldhoorn. Bart Goldhoorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Goldhoorn, Bart, et al.. (1995). Interaction of cholesterol-crystallization-promoting proteins with vesicles. Biochemical Journal. 305(1). 93–96. 6 indexed citations
2.
Seppen, Jurgen, Piter J. Bosma, Bart Goldhoorn, et al.. (1994). Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.. Journal of Clinical Investigation. 94(6). 2385–2391. 130 indexed citations
3.
Bosma, Piter J., Jurgen Seppen, Bart Goldhoorn, et al.. (1994). Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man.. Journal of Biological Chemistry. 269(27). 17960–17964. 353 indexed citations
4.
Bosma, Piter J., Bart Goldhoorn, Ronald P.J. Oude Elferink, et al.. (1993). A mutation in bilirubin uridine 5′-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Gastroenterology. 105(1). 216–220. 70 indexed citations
6.
Goldhoorn, Bart, et al.. (1992). The validity of the cholesterol nucleation assay. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1138(1). 41–45. 12 indexed citations
7.
Goldhoorn, Bart, et al.. (1990). Immunochemical analysis of uridine diphosphate-glucuronosyltransferase in four patients with the Crigler-Najjar syndrome type I.. Journal of Clinical Investigation. 85(4). 1199–1205. 39 indexed citations
8.
Bolhuis, P. A., Bart Goldhoorn, & J.G. de Groot. (1982). Normal platelet aggregation in myotonic dystrophy. Journal of the Neurological Sciences. 56(2-3). 337–342. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026